BCL2 and cancer: The PI3K/AKT signaling pathway is also aberrantly activated in malignant tumors, and the AKT protein, as a signaling hub protein, is phosphorylated and activated by membrane translocation that could catalyze the depolymerization of downstream BCL-2 and BAX to a free state43.